Goldman Sachs Group Inc Black Diamond Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $706 Billion
  • Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 350,644 shares of BDTX stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
350,644
Previous 479,387 26.86%
Holding current value
$1.47 Million
Previous $743,000 16.96%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$1.25 - $2.59 $160,928 - $333,444
-128,743 Reduced 26.86%
350,644 $869,000
Q1 2025

May 09, 2025
SELL
$1.55 - $2.73 $6,895 - $12,145
-4,449 Reduced 0.92%
479,387 $743,000
Q4 2024

Feb 11, 2025
BUY
$2.14 - $4.17 $434,034 - $845,759
202,820 Added 72.17%
483,836 $1.04 Million
Q3 2024

Nov 14, 2024
BUY
$4.2 - $6.58 $915,163 - $1.43 Million
217,896 Added 345.21%
281,016 $1.22 Million
Q2 2024

Aug 13, 2024
SELL
$4.65 - $7.39 $1.26 Million - $2 Million
-270,128 Reduced 81.06%
63,120 $294,000
Q1 2024

May 15, 2024
BUY
$2.67 - $5.74 $766,992 - $1.65 Million
287,263 Added 624.69%
333,248 $1.69 Million
Q4 2023

Feb 13, 2024
BUY
$1.77 - $3.03 $81,393 - $139,334
45,985 New
45,985 $129,000
Q1 2023

May 14, 2024
SELL
$1.35 - $3.14 $441 - $1,026
-327 Reduced 0.88%
36,679 $69,000
Q1 2023

May 11, 2023
SELL
$1.35 - $3.14 $441 - $1,026
-327 Reduced 0.88%
36,679 $69,000
Q4 2022

May 14, 2024
SELL
$1.27 - $2.51 $22,824 - $45,109
-17,972 Reduced 32.69%
37,006 $66,000
Q4 2022

Feb 13, 2023
SELL
$1.27 - $2.51 $22,824 - $45,109
-17,972 Reduced 32.69%
37,006 $66,000
Q3 2022

May 14, 2024
SELL
$1.68 - $4.01 $79,208 - $189,063
-47,148 Reduced 46.17%
54,978 $93,000
Q3 2022

Nov 10, 2022
SELL
$1.68 - $4.01 $79,208 - $189,063
-47,148 Reduced 46.17%
54,978 $0
Q2 2022

May 14, 2024
BUY
$1.5 - $3.63 $84,211 - $203,791
56,141 Added 122.09%
102,126 $251,000
Q2 2022

Aug 15, 2022
SELL
$1.5 - $3.63 $118,456 - $286,664
-78,971 Reduced 43.61%
102,126 $251,000
Q1 2022

May 16, 2022
BUY
$2.66 - $5.61 $130,183 - $274,559
48,941 Added 37.03%
181,097 $502,000
Q4 2021

Feb 14, 2022
BUY
$5.18 - $8.48 $31,339 - $51,304
6,050 Added 4.8%
132,156 $704,000
Q3 2021

Nov 10, 2021
BUY
$8.46 - $12.42 $1.07 Million - $1.57 Million
126,106 New
126,106 $1.07 Million

Others Institutions Holding BDTX

# of Institutions
99
Shares Held
41.3M
Call Options Held
0
Put Options Held
0
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $152M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email